Category: Labor
Poster Session II
490 patients were included in the study of women specifically declining eIOL in the 39th week of pregnancy. Of these, 126 (35%) delivered during the 39th week, with 75 (60%) having SOL and the remaining 51 (40%) requiring mIOL[Table 1]. In the remaining 364 women (65%), the pregnancy continued beyond the 39th week, with 195 achieving SOL (OR= 0.78; 95% CI= 0.52-1.18). On reaching 40 weeks, the risk of achieving SOL fell further (OR=0.21; 95% CI= 0.14-0.34).
Conclusion:
In this prospective study, we demonstrated that the odds of achieving SOL decreases as gestation progresses. Given that fetal and maternal risks increase with advancing gestation, this study supports the concept that eIOL is a reasonable and risk-reducing option for healthy pregnant women at 39 weeks’ gestation. Hoping for SOL will not avoid IOL in a considerable number of expectantly managed pregnancies.
Sarah M. Nicholson, MBBCH
Rotunda Hospital
Dublin, Ireland, Ireland
Corina Oprescu, MSc
Rotunda Hospital
Dublin, Ireland, Ireland
Sara El Nimr, MBBCH
Rotunda Hospital
Dublin, Ireland, Ireland
Patrick Dicker, BA, MS, MSc
Biostatistician
Royal College of Surgeons in Ireland
Dublin, Ireland, Ireland
Zara Molphy, PhD
Royal College of Surgeons in Ireland
Dublin, Ireland, Ireland
Susan Hatt, BSc, MSc
Royal college of surgeons, Ireland
Dublin, Ireland, Ireland
Eimear Curtin, N/A
Royal College of Surgeons, Ireland
Dublin, Ireland, Ireland
Leah Doyle, N/A
Royal College of Surgeons, Ireland
Dublin, Ireland, Ireland
Karen Flood, MBBCH
Royal College of Surgeons in Ireland
Dublin, Ireland, Ireland
Fergal D. Malone, MD
Obstetrician & Gynecologist
Rotunda Hospital Dublin
Dublin, Ireland